Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Jan 17, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 16.9B USD
- Positions
- 223
- Share of the ten largest
- 48.7%
The ten largest positions Q4 2023
- Coinbase 8.9%▼ −18.9%
- UiPath Inc 6.4%▼ −8.1%
- Tesla, Inc. 5.6%▼ −6.8%
- Block, Inc. 5.4%▲ +9.2%
- Roku Inc 5.2%▼ −8.7%
- Zoom Video Communications Inc 4.7%▲ +7.7%
- Roblox 3.2%▼ −0.6%
- Twilio 3.2%▼ 0.0%
- CRISPR Therapeutics AG 3.2%▲ +19.2%
- Unity Software Inc 3.0%▲ +6.2%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q4 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| XYZ Block, Inc. | 5.4% | 11,887,628 | 919.5M USD | +9.2% increased | Q4 2016 or earlier 29 quarters |
| Zoom Video Communications Inc | 4.7% | 10,964,576 | 788.5M USD | +7.7% increased | Q4 2020 13 quarters |
| CRISPR Therapeutics AG | 3.2% | 8,536,104 | 534.4M USD | +19.2% increased | Q2 2017 27 quarters |
| Unity Software Inc | 3.0% | 12,189,778 | 498.4M USD | +6.2% increased | Q3 2020 14 quarters |
| Teladoc Health Inc | 2.7% | 21,224,565 | 457.4M USD | +4.5% increased | Q3 2017 26 quarters |
| HOOD Robinhood Markets | 2.6% | 34,936,204 | 445.1M USD | +6.4% increased | Q3 2021 10 quarters |
| Intellia Therapeutics Inc | 2.1% | 11,412,449 | 348.0M USD | +14.7% increased | Q4 2016 or earlier 29 quarters |
| Pacific Biosciences of Califor | 2.0% | 34,504,273 | 338.5M USD | +15.7% increased | Q3 2019 18 quarters |
| Ginkgo Bioworks Holdings Inc | 2.0% | 198,606,619 | 335.6M USD | +9.0% increased | Q3 2021 10 quarters |
| Twist Bioscience Corp | 1.6% | 7,213,257 | 265.9M USD | +6.3% increased | Q2 2019 19 quarters |
| PagerDuty Inc | 1.6% | 11,413,423 | 264.2M USD | +8.1% increased | Q1 2020 16 quarters |
| Beam Therapeutics Inc | 1.5% | 9,393,889 | 255.7M USD | +6.9% increased | Q4 2020 13 quarters |
| 10X Genomics Inc | 1.3% | 4,041,287 | 226.2M USD | +35.0% increased | Q2 2020 15 quarters |
| Veracyte Inc | 1.2% | 7,655,603 | 210.6M USD | +0.8% increased | Q4 2016 or earlier 29 quarters |
| Recursion Pharmaceuticals Inc | 1.2% | 20,654,287 | 203.7M USD | +200.4% increased | Q2 2021 11 quarters |
| PLTR Palantir Technologies | 1.1% | 10,937,859 | 187.8M USD | +16.1% increased | Q2 2023 3 quarters |
| TER Teradyne | 1.0% | 1,500,456 | 162.8M USD | +5.5% increased | Q4 2016 or earlier 29 quarters |
| TTD The Trade Desk | 0.9% | 2,149,654 | 154.7M USD | +1,162.0% increased | Q2 2023 3 quarters |
| ACHR Archer Aviation | 0.9% | 24,907,280 | 152.9M USD | +4.7% increased | Q3 2021 10 quarters |
| META Meta Platforms | 0.6% | 309,363 | 109.5M USD | +7.8% increased | Q2 2023 3 quarters |
| Schrodinger Inc/United States | 0.6% | 3,053,521 | 109.3M USD | +7.7% increased | Q2 2020 15 quarters |
| Verve Therapeutics Inc | 0.6% | 7,025,116 | 97.9M USD | +35.1% increased | Q2 2021 11 quarters |
| Iridium Communications Inc | 0.5% | 2,173,964 | 89.5M USD | +12.9% increased | Q3 2019 18 quarters |
| CareDx Inc | 0.5% | 7,194,722 | 86.3M USD | +7.7% increased | Q2 2019 19 quarters |
| Accolade Inc | 0.5% | 6,805,208 | 81.7M USD | +12.6% increased | Q3 2020 14 quarters |
| Arcturus Therapeutics Holdings | 0.4% | 2,047,687 | 64.6M USD | +7.7% increased | Q2 2019 19 quarters |
| Adaptive Biotechnologies Corp | 0.4% | 12,806,513 | 62.8M USD | +11.3% increased | Q2 2020 15 quarters |
| Pinterest Inc | 0.3% | 1,444,579 | 53.5M USD | +152.3% increased | Q1 2023 4 quarters |
| Adyen NV | 0.3% | 40,246 | 51.9M USD | +2.6% increased | Q1 2019 20 quarters |
| VRTX Vertex Pharmaceuticals | 0.3% | 124,197 | 50.5M USD | +7.7% increased | Q3 2020 14 quarters |
| 908 Devices Inc | 0.3% | 4,346,579 | 48.8M USD | +8.3% increased | Q4 2020 13 quarters |
| AMD Advanced Micro Devices | 0.3% | 310,882 | 45.8M USD | +16.7% increased | Q1 2023 4 quarters |
| Cerus Corp | 0.3% | 20,914,326 | 45.2M USD | +4.2% increased | Q4 2016 or earlier 29 quarters |
| Global-e Online Ltd | 0.3% | 1,133,401 | 44.9M USD | +7.0% increased | Q1 2022 8 quarters |
| VEEV Veeva Systems | 0.3% | 226,786 | 43.7M USD | +13.5% increased | Q4 2020 13 quarters |
| MRNA Moderna | 0.3% | 437,403 | 43.5M USD | +68.3% increased | Q3 2022 6 quarters |
| Toast Inc | 0.3% | 2,345,520 | 42.8M USD | +101.5% increased | Q3 2021 10 quarters |
| Genius Sports Ltd | 0.3% | 6,914,013 | 42.7M USD | +9.9% increased | Q3 2021 10 quarters |
| NET Cloudflare | 0.2% | 440,868 | 36.7M USD | +2.6% increased | Q4 2020 13 quarters |
| SomaLogic Inc | 0.2% | 14,241,979 | 36.0M USD | +9.7% increased | Q3 2022 6 quarters |
| INCY Incyte | 0.2% | 531,625 | 33.4M USD | +7.7% increased | Q4 2016 or earlier 29 quarters |
| Nurix Therapeutics Inc | 0.2% | 3,194,999 | 33.0M USD | +23.2% increased | Q4 2021 9 quarters |
| Quantum-Si Inc | 0.2% | 15,519,322 | 31.2M USD | +7.4% increased | Q2 2021 11 quarters |
| Prime Medicine Inc | 0.2% | 3,138,270 | 27.8M USD | +19.7% increased | Q4 2022 5 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 0.2% | 249,821 | 26.0M USD | +24.3% increased | Q2 2023 3 quarters |
| Compass Pathways Plc | 0.1% | 2,618,871 | 22.9M USD | +7.6% increased | Q3 2022 6 quarters |
| JOBY Joby Aviation | 0.1% | 3,404,900 | 22.6M USD | +7.2% increased | Q3 2021 10 quarters |
| MSFT Microsoft | 0.1% | 58,306 | 21.9M USD | +14.4% increased | Q4 2016 or earlier 29 quarters |
| Spotify Technology SA | 0.1% | 113,178 | 21.3M USD | +0.2% increased | Q2 2018 23 quarters |
| Repare Therapeutics Inc | 0.1% | 2,821,560 | 20.6M USD | +7.7% increased | Q4 2020 13 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 94 positions.
Breakdown by sector
- Financials 17.1%
- Technology 7.9%
- Consumer Discretionary 5.7%
- Industrials 1.6%
- Health Care 1.3%
- Communication Services 0.8%
- not in our coverage 65.5%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors